Characterization of human embryonic stem cells with features of neoplastic progression

Cultured human embryonic stem (hES) cells can acquire genetic and epigenetic changes that make them vulnerable to transformation. As hES cells with cancer-cell characteristics share properties with normal hES cells, such as self-renewal, teratoma formation and the expression of pluripotency markers, they may be misconstrued as superior hES cells with enhanced 'stemness'. We characterize two variant hES cell lines (v-hESC-1 and v-hESC-2) that express pluripotency markers at high levels and do not harbor chromosomal abnormalities by standard cytogenetic measures. We show that the two lines possess some features of neoplastic progression, including a high proliferative capacity, growth-factor independence, a 9- to 20-fold increase in frequency of tumor-initiating cells, niche independence and aberrant lineage specification, although they are not malignant. Array comparative genomic hybridization reveals an amplification at 20q11.1-11.2 in v-hESC-1 and a deletion at 5q34a-5q34b;5q3 and a mosaic gain of chromosome 12 in v-hESC-2. These results emphasize the need for functional characterization to distinguish partially transformed and normal hES cells.

[1]  E. Blennow,et al.  Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. , 2004, Molecular human reproduction.

[2]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[3]  M. Hendrix,et al.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells , 2008, Proceedings of the National Academy of Sciences.

[4]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[5]  Sean C. Bendall,et al.  Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment , 2006, Nature Methods.

[6]  A. Chakravarti,et al.  Genomic alterations in cultured human embryonic stem cells , 2005, Nature Genetics.

[7]  T. Ince,et al.  The terminology of teratocarcinomas and teratomas , 2007, Nature Biotechnology.

[8]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[9]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[10]  Ernst Wolvetang,et al.  CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells , 2006, Nature Biotechnology.

[11]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[12]  J. Thomson,et al.  Basic Fibroblast Growth Factor Support of Human Embryonic Stem Cell Self‐Renewal , 2006, Stem cells.

[13]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[14]  H. Lodish.  Molecular Cell Biology , 1986 .

[15]  E. Hook.  Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. , 1977, American journal of human genetics.

[16]  T. Enver,et al.  Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. , 2005, Human molecular genetics.

[17]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[18]  Takumi Miura,et al.  Long‐term culture of human embryonic stem cells in feeder‐free conditions , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  M. Peschanski,et al.  Human embryonic stem cells reveal recurrent genomic instability at 20q11.21 , 2008, Nature Biotechnology.

[20]  Steven L. Stice,et al.  Preserving the genetic integrity of human embryonic stem cells , 2005, Nature Biotechnology.

[21]  G. Lin,et al.  Tumor progression of culture‐adapted human embryonic stem cells during long‐term culture , 2008, Genes, chromosomes & cancer.

[22]  Gunilla Caisander,et al.  Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture , 2006, Chromosome Research.

[23]  Chad A. Cowan,et al.  Derivation of embryonic stem-cell lines from human blastocysts. , 2004, The New England journal of medicine.

[24]  E. Blennow,et al.  In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells , 2006, Journal of cellular biochemistry.

[25]  J. Zeitlinger,et al.  Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.

[26]  J. Thomson,et al.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.

[27]  Ian A. White,et al.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.

[28]  W. Freed,et al.  Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. , 2004, Stem cells and development.

[29]  Sean C. Bendall,et al.  IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro , 2007, Nature.

[30]  K. Sermon,et al.  Recurrent chromosomal abnormalities in human embryonic stem cells , 2008, Nature Biotechnology.

[31]  Lisheng Wang,et al.  Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. , 2003, Blood.

[32]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.